000 01505 a2200421 4500
005 20250512102351.0
264 0 _c19721129
008 197211s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/1097-0142(197209)30:3<621::aid-cncr2820300305>3.0.co;2-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBergsagel, D E
245 0 0 _aLung cancer: clinical trial of radiotherapy alone vs. radiotherapy plus cyclophosphamide.
_h[electronic resource]
260 _bCancer
_cSep 1972
300 _a621-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aCarcinoma
_xdrug therapy
650 0 4 _aCarcinoma, Small Cell
_xdrug therapy
650 0 4 _aCarcinoma, Squamous Cell
_xdrug therapy
650 0 4 _aCobalt Isotopes
650 0 4 _aCyclophosphamide
_xadministration & dosage
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aInjections, Intravenous
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMediastinum
650 0 4 _aNeoplasm Metastasis
650 0 4 _aTime Factors
700 1 _aJenkin, R D
700 1 _aPringle, J F
700 1 _aWhite, D M
700 1 _aFetterly, J C
700 1 _aKlaassen, D J
700 1 _aMcDermot, R S
773 0 _tCancer
_gvol. 30
_gno. 3
_gp. 621-7
856 4 0 _uhttps://doi.org/10.1002/1097-0142(197209)30:3<621::aid-cncr2820300305>3.0.co;2-0
_zAvailable from publisher's website
999 _c4347257
_d4347257